Navigation Links
Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
Date:10/5/2009

ST. LOUIS and RICHMOND, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals. Additionally, Sigma-Aldrich licensed rights to certain ZFP-engineered transgenic animals for commercial applications.

"The zinc finger technology platform developed by Sangamo is a core component of Sigma-Aldrich's growth strategy into high-value biologic tools," said Jai Nagarkatti, Sigma-Aldrich's Chairman, President and CEO. "We have experienced tremendous interest from the academic and biotechnology research community in our CompoZr(TM) zinc finger nuclease (ZFN) platform of reagents. Expanding our capability to provide ZFN-modified cells for the commercial production of therapeutic proteins and vaccines takes us into markets with enormous commercial potential, and we fully intend to maximize the value of these assets."

"ZFN-based gene editing is rapidly emerging as a critical tool in modern biotechnology," said David Smoller, Ph.D., President of Sigma-Aldrich's Research Biotech Business Unit. "The ability to modify genes in essentially any cell type has been established. In addition, we are now able to generate transgenic animals in species in which it was previously impossible to efficiently and specifically carry out genome modification. This opens up endless possibilities for application and commercialization of the ZFP technology platform."

"We are delighted with our partnership with Sigma-Aldrich," said Edward La
'/>"/>

SOURCE Sigma-Aldrich Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in Peer-Reviewed Video Journal JoVE
2. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMeds Peer-Reviewed Video Journal JoVE
3. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
4. Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells
5. Sangamo BioSciences Reports Second Quarter 2009 Financial Results
6. Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
7. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
8. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
9. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
10. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
11. Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... CA. (PRWEB) , ... July 29, 2015 , ... ... with PRC Clinical, a Silicon Valley-based CRO specializing in Clinical Trial ... services, and patient recruitment services. The core expertise of PRC Clinical is focused ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Nearly everyone has ... diseases. Yet few people realize that a rich source of these cells is teeth—baby ... and teeth that need to be pulled to make room for braces. These ...
(Date:7/28/2015)... July 28, 2015 People with a common ... achieved significant and sometimes profound improvements in their hearing ... according to a new multicenter study led by specialists ... study, described online ahead of print in the journal The ... private clinics in the United States ...
(Date:7/28/2015)... ... July 28, 2015 , ... VetStem Biopharma will be ... cell credentialing course to local area veterinarians. , The tour and course will be ... at no charge) at VetStem’s Poway facility. Staff members are welcome to attend with ...
Breaking Biology Technology:CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Tooth™ Dental Stem Cell Banking Available to their Patients 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2
... clearance for two new brain imaging applications, a local ... products to healthcare providers. , ,Approval from the ... Radiologic Health in June allowed Kyron Clinical ... line of brain mapping solutions based on functional and ...
... , Wis. - Platypus Technologies recently ... new line of products and court strategic partners - ... and nanotechnology company is prepared to expand its product ... used by researchers, and management is in discussions with ...
... Wis. - Local angel investor network Silicon ... Clearent, LLC , which is developing a next-generation credit ... , ,It's not unusual for Wisconsin-based investors to look ... of Silicon Pastures, said this investment opportunity arrived at ...
Cached Biology Technology:Kyron wins FDA approval for brain imaging technology 2Platypus ready to unveil new commercial lines 2Platypus ready to unveil new commercial lines 3Platypus ready to unveil new commercial lines 4
(Date:7/2/2015)... , June 25, 2015 ... announced the addition of the "Natural Language ... Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) ... their offering. The key vendors occupying ... HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:6/24/2015)... YORK , June 24, 2015 The ... rate. The major drivers for the market include growth ... number of new drug launches. Over the years, the ... increased. Between 2001 and 2010, the FDA approved 225 ... according to WIPO, Europe accounted ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... BOZEMAN, Mont. -- Research by a Montana State ... paleontologists is upending more than 100 years of thought ... Since the late 1800s, scientists have believed that Triceratops ... had a three-horned skull with a rather short frill, ...
... Rice University scientists have found the "ultimate" solvent for ... brings the creation of a highly conductive quantum nanowire ... of bundling, making them less useful than when they,re ... Pasquali, a professor in chemical and biomolecular engineering and ...
... of care comprised of surgery, radiation and chemotherapy ... number of biological responses that may actually feed the energy ... writing in the journal Lancet Oncology . The ... of about a year from diagnosis. Just three percent of ...
Cached Biology News:Montana State researchers say Triceratops, Torsaurus were same dinosaur at different stages 2Montana State researchers say Triceratops, Torsaurus were same dinosaur at different stages 3Montana State researchers say Triceratops, Torsaurus were same dinosaur at different stages 4Nanotubes pass acid test 2Nanotubes pass acid test 3Does the existing standard of care supply energy sources to brain tumor cells? 2